GPC5,A Novel Epigenetically Silenced Tumor Suppressor, Inhibits Tumor Growth by Suppressing Wntβ-cat

来源 :2016第九届世界癌症大会 | 被引量 : 0次 | 上传用户:aulifo
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Glypican-5 (GPC5) is a member of the heparin sulfate proteoglycans.In present study,we confirmed that GPC5 was downregulated in lung adenocarcinoma tissues compared with adjacent normal lung tissues.
其他文献
  In this presentation, we report from the front lines of a health care transformation in Singapore.There is a movement towards a patient-centred, generalist
会议
会议
会议
会议
会议
  The oncolytic virus was recently become a very hot topic and OncoHSV-GM-CSF has been licensed to be marketed by FDA.We innovate the Cancer Targeting Gene-Vi
会议
会议
会议
  Precision (or personalized) cancer therapy matches patients with therapies based upon specific biomarkers (mutations leading to neo-antigens;cell surface an
会议